Practice Pearls for Narcolepsy Management
Richard K. Bogan, MD, FCCP, FAASM, and Asim Roy, MD, share take-home messages for the management of narcolepsy.
Case #2: 29-Year-Old Male With Type 2 Narcolepsy
Experts in sleep medicine present a case of a 29-year-old male with EDS, vivid dreams, sleep paralysis, and adult ADD, and share their initial impressions.
Case #1: 18-Year-Old Female With Type 1 Narcolepsy
Sleep experts present a case of an 18-year-old female preparing for college with EDS and cataplexy, and share their approach to treatment.
Unmet Needs in Narcolepsy Treatment
Drs Asim Roy and Richard K. Bogan discuss remaining unmet needs in the therapeutic landscape for narcolepsy.
Newer Agents for the Management of Narcolepsy
Richard K. Bogan, MD, FCCP, FAASM, and Asim Roy, MD, comment on the evolving treatment landscape for narcolepsy and patient selection of FDA-approved agents: solriamfetol, pitolisant, and lower-sodium oxybate.
Therapeutic Options for the Management of Narcolepsy
Experts in sleep medicine share insight on initiating treatment for the management of narcolepsy.
Diagnosis of Narcolepsy and Impact on QoL
Sleep experts comment on diagnostic criteria for narcolepsy, factors that may lead to misdiagnosis, and the impact of the condition on a patient’s quality of life.
Overview and Triggers of Narcolepsy
Richard K. Bogan, MD, FCCP, FAASM, and Asim Roy, MD, provide an overview of the pathophysiology of narcolepsy and the role of orexin in regulating the sleep/wakefulness cycle.
2 Clarke Drive Cranbury, NJ 08512